Doctor profile · Federal record

Dr. Harry Moore, M.D.

Medical Oncology Physician (CMS: Hematology/Oncology) · Specialist · Internal Medicine Physician · Macon, GA

  • NPI 1699096388
  • Accepts Medicare
  • MIPS 97.9 / 100 · 2023
  • 28 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
800 First Street, Suite 410, Central Georgia Cancer Center, PC,
Macon, GA 312018300
(478) 743-7068
fax (478) 741-1354

Credentials & registration

NPPES · NUCC
NPI registered
June 2010 — 16 yrs on file
Profile last updated
September 2, 2025
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (2)
Georgia #69071 · Florida #4288
Medicaid (5)
GA #003160240F · GA #003160240A · GA #003160240G · GA #003160240H · GA #003160240B

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1699096388. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
203,353
Distinct HCPCS
10
Medicare allowed
$3,647,030
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 38,985 44 $1
J9271 Injection, pembrolizumab, 1 mg 28,200 48 $54
J9263 Injection, oxaliplatin, 0.5 mg 19,176 20 $0
J9299 Injection, nivolumab, 1 mg 15,840 14 $30
J0897 Injection, denosumab, 1 mg 12,720 66 $23
J1453 Injection, fosaprepitant, 1 mg 10,200 51 $0
J9025 Injection, azacitidine, 1 mg 9,775 12 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 8,435 70 $0
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 8,280 17 $48
J9264 Injection, paclitaxel protein-bound particles, 1 mg 6,450 11 $13

In context: peer comparison

Among 1 peers in Macon Medical Oncology Physician, average services per provider: 2,392. This provider delivers 85× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,291
Transactions
101
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Pfizer INC. 18 $301.10
Abbvie INC. 11 $270.85
Myriad Genetic Laboratories, INC. 3 $230.96
Genentech USA, INC. 8 $225.23
Daiichi Sankyo INC. 8 $174.26
Merck Sharp & Dohme LLC 8 $173.87
Regeneron Healthcare Solutions, INC. 6 $161.61
AstraZeneca Pharmaceuticals Lp 7 $151.19
Novartis Pharmaceuticals Corporation 5 $131.17
Takeda Pharmaceuticals U.S.A., INC. 4 $117.76
Gilead Sciences, INC. 5 $114.46
Exelixis INC. 6 $112.16
Astellas Pharma US INC 5 $91.47
Jazz Pharmaceuticals INC. 3 $81.02
Adaptive Biotechnologies Corporation 4 $78.95

By nature of payment

Food and Beverage
$3,179
Education
$112

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,056
Patients
313
Total drug cost
$1,563,240
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 178 72 $4,806
Anastrozole Generic 164 34 $3,771
Letrozole Generic 142 37 $5,105
Oxycodone Hcl Generic 94 47 $1,738
Hydroxyurea Generic 66 18 $2,369
Gabapentin Generic 60 18 $779
Eliquis (Apixaban) Brand 58 14 $38,426
Morphine Sulfate ER (Morphine Sulfate) Brand 49 23 $1,712
Dexamethasone Generic 48 14 $403
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 43 19 $812

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Harry Moore's medical specialty?
Dr. Harry Moore practices Medical Oncology Physician in Macon, GA.
Where does Dr. Harry Moore practice?
Dr. Harry Moore practices at 800 First Street, Suite 410, Macon, GA 312018300. Office phone: 4787437068.
What is Dr. Harry Moore's NPI?
Dr. Harry Moore's National Provider Identifier (NPI) is 1699096388, issued by NPPES.
Does Dr. Harry Moore accept Medicare assignment?
Yes. Dr. Harry Moore accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Harry Moore commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, oxaliplatin, 0.5 mg (HCPCS J9263). Source: CMS Medicare Physician & Other Practitioners file.